Cytochroma and Genzyme settle lawsuit

The lawsuit was originally filed in August 2006 by Genzyme Corporation against Cytochroma, Proventiv Therapeutics LLC and three former Bone Care International employees.

The complaint alleged misappropriation of Vitamin D-related trade secrets. The case has now been formally dismissed. The terms of the settlement were not disclosed.

“Cytochroma has remained on track for meeting its financing and clinical development milestones despite the intercurrent lawsuit,” commented Dr Alan Lewis, chairman of the board. “The recent settlement with Genzyme adds further momentum to Cytochroma for achieving its corporate objectives.”